There are no products listed under this category.
DUSP26
DUSP26 (dual specificity phosphatase 26, also known as DUSP24, NEAP and MGC1136) is an atypical dual specificity phosphatase that removes phosphate groups from tyrosine, serine and threonine residues. It regulates MAP kinase signalling and has been described as both a tumour suppressor and an oncogene. Browse Assay Genie's current range of DUSP26 research reagents below, or read on for the biology behind the target.
DUSP26 belongs to the protein-tyrosine phosphatase family, in the non-receptor class dual specificity subfamily. It dephosphorylates tyrosine as well as serine and threonine residues. Its best-described substrates are MAP kinases. It inactivates MAPK1 and MAPK3, which leads to dephosphorylation of heat shock factor protein 4 and a reduction in its DNA-binding activity. It also inhibits MAP kinase p38 by dephosphorylating it, and in this way inhibits p38-mediated apoptosis in anaplastic thyroid cancer cells. The enzyme can also induce activation of p38 and c-Jun N-terminal kinase (JNK), so its effect on stress-activated kinase signalling depends on context.
The human DUSP26 gene encodes a protein that UniProt places in the cytoplasm, nucleus and Golgi apparatus. HGNC classes it among the atypical dual specificity phosphatases. Alternative splicing of the gene gives multiple transcript variants. Mouse and rat both carry an orthologue named Dusp26, which allows the protein to be studied in rodent models.
NCBI Gene notes that DUSP26 has been described as both a tumour suppressor and an oncogene, depending on the cellular context. The protein may regulate neuronal proliferation. It has also been implicated in the progression of glioblastoma through its ability to dephosphorylate the p53 tumour suppressor. The gene was previously listed as dual specificity phosphatase 26 (putative), and it has also appeared under the symbols DUSP24, NEAP and MGC1136. Researchers who study the DUSP26 protein often do so in the context of MAPK signalling, apoptosis and cancer biology.
DUSP26 inactivates MAPK1 and MAPK3 and acts on p38, which makes it a useful node for studying kinase regulation.
DUSP26 has been described as both a tumour suppressor and an oncogene, so its role depends on the cellular context.
DUSP26 has been implicated in glioblastoma progression through dephosphorylation of the p53 tumour suppressor.
DUSP26 inhibits p38-mediated apoptosis in anaplastic thyroid cancer cells and can also activate p38 and JNK.
DUSP26 is a dual specificity phosphatase that dephosphorylates tyrosine, serine and threonine residues. It inactivates MAPK1 and MAPK3, dephosphorylates and inhibits p38, and can also induce activation of p38 and JNK. Its action on heat shock factor protein 4 reduces that protein's DNA-binding activity.
DUSP26 is also known as DUSP24, NEAP and MGC1136. Its earlier name was dual specificity phosphatase 26 (putative). UniProt lists it as dual specificity protein phosphatase 26. NCBI Gene reports that alternative splicing produces multiple transcript variants.
Mouse and rat each have an orthologue called Dusp26; check the datasheet of any product for its validated reactivity. In humans, DUSP26 has been described as a tumour suppressor and as an oncogene, and it is implicated in glioblastoma progression through p53 dephosphorylation.
Other dual specificity phosphatases that regulate MAP kinase signalling, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9BV47; product specifications from Assay Genie datasheets.
There are no products listed under this category.